# Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer

> **NCT06418126** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Centre Paul Strauss** · enrollment: 15 (estimated)

## Conditions studied

- Triple-negative Breast Cancer

## Interventions

- **BIOLOGICAL:** blood sampling before radiotherapy
- **BIOLOGICAL:** blood sampling after the fourth radiotherapy session
- **OTHER:** collection of acute toxicity (radiodermatitis)
- **OTHER:** collection of late toxicity
- **OTHER:** collection of disease status
- **RADIATION:** Radiotherapy - Breast +/- lymph node areas
- **RADIATION:** Radiotherapy - Boost operating bed

## Key facts

- **NCT ID:** NCT06418126
- **Lead sponsor:** Centre Paul Strauss
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-11
- **Primary completion:** 2025-10-07
- **Final completion:** 2030-08-19
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06418126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06418126, "Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06418126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*